BioGlue or Vivostat in the Control of Air Leak in Thoracic Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00927342|
Recruitment Status : Completed
First Posted : June 24, 2009
Last Update Posted : June 24, 2009
Following lung surgery air may continue to leak from the surface of the lung. Chest drains are placed to allow this air to be removed safely and prevent the lung from collapsing. Drains need to remain until the air leak from the lung has ceased.
Air which continues to leak results in longer chest drainage times which cause increased discomfort and immobility for patients. These patients are at risk of secondary complications such as infection. Longer hospital stays and increased costs ensue. A randomised controlled trial (RCT) conducted at The Royal Brompton Hospital has shown clear benefits in the management of difficult air leak with the use of BioGlue. BioGlue is a surgical sealant applied to the surface of the lung at the time of surgery.
BioGlue is of bovine origin. Concerns exist regarding the potential risk of transmission of blood borne diseases with bovine derived medical products. Should a surgical adhesive without these potential risks prove as effective as BioGlue then its use could be commended.
The Vivostat System is a medical system that derives a sealant from the patient's own blood. A small study has shown that it may also be of benefit in the management of difficult air leaks. The principal aim of our RCT is to compare the duration of air leak, length of chest drainage and hospital stay associated with BioGlue to that of Vivostat.
|Condition or disease||Intervention/treatment|
|Thoracic Surgery Air Leak||Other: Vivostat Other: BioGlue|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||103 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Comparison of BioGlue and Vivostat in the Prevention of Air Leak in Thoracic Surgery|
|Study Start Date :||December 2005|
|Primary Completion Date :||December 2007|
|Study Completion Date :||December 2007|
|Active Comparator: Vivostat||
Patients with an air leak at the end of thoracic surgery despite conventional measures(diathermy, suturing and/or stapling) will receive Vivostat sealant applied to the surface of the lung in an attempt to eliminate air leak
|Active Comparator: BioGlue||
Patients with an air leak at the end of thoracic surgery despite conventional measures(diathermy, suturing and/or stapling) will receive Bioglue sealant applied to the surface of the lung in an attempt to eliminate air leak
- Duration of air leak [ Time Frame: Days post-operatively ]
- Duration of intercostal drainage [ Time Frame: Days post-operatively ]
- Duration of hospital stay [ Time Frame: Days post-operatively ]
- Post-operative complications [ Time Frame: Days and weeks following discharge ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00927342
|Department of Thoracic Surgery, The Royal Brompton Hospital|
|London, United Kingdom, SW3 6NP|